Skip to main content

Atopic Dermatitis Disease Complications

  • Chapter
  • First Online:
Management of Atopic Dermatitis

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 1027))

Abstract

This chapter will describe infectious complications of atopic dermatitis, including bacterial, viral, and fungal infections and the evolving understanding of the relationship between atopic dermatitis and infectious disease. The underlying immunological dysregulation and poor skin barrier function associated with atopic dermatitis not only increases the likelihood of infectious complications, but also lends atopic dermatitis skin vulnerable to flares induced by environmental triggers. Thus, this chapter will also highlight the impact of common external environmental agents on precipitating flares of disease. Lastly, this chapter will discuss complications that can arise from treatments and the association of atopic dermatitis with more serious conditions such as lymphoma.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Sun D, Ong PY. Infectious complications in atopic dermatitis. Immunol Allergy Clin North Am. 2017;37(1):75–93. http://www.ncbi.nlm.nih.gov/pubmed/27886912. Accessed 26 Dec 2016.

    Article  CAS  PubMed  Google Scholar 

  2. Elias PM, Hatano Y, Williams ML. Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms. J Allergy Clin Immunol. 2008;121:1337–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Lin YT, Wang CT, Chiang BL. Role of bacterial pathogens in atopic dermatitis. Clin Rev Allergy Immunol. 2007;33(3):167–77. http://www.ncbi.nlm.nih.gov/pubmed/18163223.

    Article  CAS  PubMed  Google Scholar 

  4. Bieber T. Atopic dermatitis. N Engl J Med. 2008;358(14):1483–94.

    Article  CAS  PubMed  Google Scholar 

  5. Leung DYM. Our evolving understanding of the functional role of filaggrin in atopic dermatitis. J Allergy Clin Immunol. 2009;124(3):494–5. doi:10.1016/j.jaci.2009.07.041.

    Article  CAS  PubMed  Google Scholar 

  6. Ong PY, Leung DYM. Bacterial and viral infections in atopic dermatitis: a comprehensive review. Clin Rev Allergy Immunol. 2016;51(3):329–37. doi:10.1007/s12016-016-8548-5.

    Article  CAS  PubMed  Google Scholar 

  7. Higaki S, et al. Comparative study of staphylococci from the skin of atopic dermatitis patients and from healthy subjects. Int J Dermatol. 1999;38(4):265–9.

    Article  CAS  PubMed  Google Scholar 

  8. Leung DYM, Bieber T. Atopic dermatitis. Lancet. 2003;361(9352):151–60.

    Google Scholar 

  9. Leyden JJ, Marples RR, Kligman AM. Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol. 1974;90(5):525–30.

    Article  CAS  PubMed  Google Scholar 

  10. Ong PY, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med. 2002;347(15):1151–60. doi:10.1056/NEJMoa021481.

    Article  CAS  PubMed  Google Scholar 

  11. Novak N, Bieber T, Leung DYM. Immune mechanisms leading to atopic dermatitis. J Allergy Clin Immunol. 2003;112(Suppl 6):128–39.

    Article  Google Scholar 

  12. Leung DYM. The role of Staphylococcus aureus in atopic eczema. Acta Derm Venereol. 2008;216:21–7.

    Article  CAS  Google Scholar 

  13. Lübbe J. Secondary infections in patients with atopic dermatitis. Am J Clin Dermatol. 2003;4(9):641–54. https://www.scopus.com/inward/record.uri?eid=2-s2.0-.

    Article  PubMed  Google Scholar 

  14. Boguniewicz M, Leung DYM. Recent insights into atopic dermatitis and implications for management of infectious complications. J Allergy Clin Immunol. 2010;125(1):4–13. doi:10.1016/j.jaci.2009.11.027.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Hung S-H, et al. Staphylococcus colonization in atopic dermatitis treated with fluticasone or tacrolimus with or without antibiotics. Ann Allergy Asthma Immunol. 2007;98(1):51–6. http://www.ncbi.nlm.nih.gov/pubmed/17225720.

    Article  CAS  PubMed  Google Scholar 

  16. Gonzalez ME, et al. Cutaneous microbiome effects of fluticasone propionate cream and adjunctive bleach baths in childhood atopic dermatitis. J Am Acad Dermatol. 2016;75(3):481–493.e8. http://linkinghub.elsevier.com/retrieve/pii/S0190962216302067.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Leung DYM. Infection in atopic dermatitis. Curr Opin Pediatr. 2003;15(4):399–404.

    Article  PubMed  Google Scholar 

  18. Faergemann J. Atopic dermatitis and fungi. Clin Microbiol Rev. 2002;15(4):545–63.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Williams H, et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhood. J Allergy Clin Immunol. 1999;103(1):125–38.

    Article  CAS  PubMed  Google Scholar 

  20. Sidbury R, Tom WL, et al. Guidelines of care for the management of atopic dermatitis: section 4. Prevention of disease flares and use of adjunctive therapies and approaches. J Am Acad Dermatol. 2014;71(6):1218–33. doi:10.1016/j.jaad.2014.08.038.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Boguniewicz M, Schmid-Grendelmeier P, Leung DYM. Atopic dermatitis. J Allergy Clin Immunol. 2006;118(1):40–3. http://www.ncbi.nlm.nih.gov/pubmed/16815136.

  22. Sidbury R, Davis DM, et al. Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol. 2014;71(2):327–49. doi:10.1016/j.jaad.2014.03.030.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Eichenfield LF, et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014;71(1):116–32. doi:10.1016/j.jaad.2014.03.023.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Wasserbauer N, Ballow M. Atopic dermatitis. Am J Med. 2009;122(2):121–5. doi:10.1016/j.amjmed.2008.09.014.

    Article  PubMed  Google Scholar 

  25. Legendre L, et al. Risk of lymphoma in patients with atopic dermatitis and the role of topical treatment: a systematic review and meta-analysis. J Am Acad Dermatol. 2015;72(6):992–1002. doi:10.1016/j.jaad.2015.02.1116.

    Article  PubMed  Google Scholar 

  26. Margolis DJ, et al. Association Between Malignancy and Topical Use of Pimecrolimus. JAMA dermatology. 2015;151(6):594–9. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi? artid=4465068&tool=pmcentrez&rendertype=abstract.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shawn G. Kwatra M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Ashbaugh, A.G., Kwatra, S.G. (2017). Atopic Dermatitis Disease Complications. In: Fortson, E., Feldman, S., Strowd, L. (eds) Management of Atopic Dermatitis. Advances in Experimental Medicine and Biology, vol 1027. Springer, Cham. https://doi.org/10.1007/978-3-319-64804-0_5

Download citation

Publish with us

Policies and ethics